Insmed Inc (STU:IM8N)
€ 67 0.5 (0.75%) Market Cap: 11.95 Bil Enterprise Value: 11.50 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 63/100

Insmed Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:00PM GMT
Release Date Price: €26.4 (-0.75%)
Jessica Fye
J.P. Morgan Securities LLC - Analyst

My name is Jess Fye. I am a senior biotech analyst at JPMorgan, and we are continuing the 42nd Annual Healthcare Conference today with Insmed. I'm joined by the company's CEO, Will Lewis, who is going to give a presentation. And after that, we're going to move into a Q&A session. If you're in the room, you can raise your hand and we'll give you a mic or you can always use the portal to send questions to me on that iPad over there. But without any further ado, let me pass it over to Will.

Will Lewis Insmed Incorporated;President
CEO & Chairman

Thank you, Jess. It is a pleasure to be here today at what is undoubtedly a very exciting moment in Insmed's history. I'm going to be making some forward-looking statements today. Please review the notice on slide 2 and our public filings for more information.

On slide 3, we have framed out that this is the year of Insmed's transformation. I want to open by saying that what I'm about to communicate to you is going to sound incredibly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot